Status:
RECRUITING
CAPA In-vitro Oocyte Maturation
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Infertility, Female
Eligibility:
FEMALE
Up to 50 years
Phase:
NA
Brief Summary
In vitro oocyte maturation (IVM) is a mild-approach assisted reproductive technology (ART). Because of its simplicity, the more favorable financial implications (reduced cost) for patients, and the lo...
Eligibility Criteria
Inclusion
- Patients aged from 0-50 years old
- Patients seek fertility preservation services
- Patients seek oocyte retrieval services
Exclusion
- Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
Key Trial Info
Start Date :
November 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2032
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06984081
Start Date
November 10 2025
End Date
May 31 2032
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong